Cytarabine
Cytarabine, Depocyt, Vyxeos (cytarabine) is a small molecule pharmaceutical. Cytarabine was first approved as Cytarabine on 1982-01-01. It is used to treat leukemia, lymphoma, and meningeal neoplasms in the USA. It has been approved in Europe to treat myeloid leukemia acute.
Trade Name | Vyxeos liposomal, known as Vyxeos |
---|---|
Common Name | Cytarabine |
Indication | leukemia, lymphoma, meningeal neoplasms, myeloid leukemia acute |
Drug Class | Antineoplastics (arabinofuranosyl derivatives) |